Seno Medical gets FDA nod for Imagio breast cancer diagnostic technology
Seno Medical Instruments has secured premarket approval (PMA) from the Centre for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) for its diagnostic